Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.

Clarity is a personalized medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. Clarity’s platform technology allows antibodies to be radiolabeled and visualized using PET imaging. The human imaging data generated provides information on whether the drug reaches the desired disease target in a patient. This information enables a personalized approach to therapy by only treating those patients that are likely to respond to therapy and excluding those that won’t respond to therapy. This precision medicine approach is at the forefront of drug development.

Tianjin Nano Biotechnology Co., Ltd., established on 2017-01-05, Business scope includes biotechnology development,transfer,consultation service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Beijing Senmiao Biotechnology Co., Ltd., established on 2020-03-02, Business scope includes technical development of bioengineering,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Technical Services;Medical Research and Experimental Development;Sell ​​self-developed products.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Tianjin Gudui Biomedical Technology Co., Ltd., established on 2010-08-26, Business scope includes biological(except narcotics)technology development,consult,Serve,transfer.(The country has a special,Franchised,Execute according to regulations.)

Genelux Corporation is a privately-held, clinical-stage biopharmaceutical company that has developed a proprietary oncolytic virus-based technology platform and a deep pipeline of products with broad applications for cancer detection and therapy. GL-ONC1 the company’s lead oncology product candidate is an attenuated vaccinia virus (Lister strain) that results in dramatic regression and elimination of a wide range of solid tumors in animals without damaging healthy tissues or organs. GL-ONC1 encodes Green Fluorescent Protein (GFP) to enable highly selective imaging of tumors and metastases as an aid in the diagnosis and staging of cancer. GL-ONC1 is currently under evaluation in Phase I/II human clinical trials in the United States and Europe, and additional US and European-based trials are set to begin in the near future. GL-ONC1 is proving well-tolerated with minimal side effects and showing early signs of anti-tumor activity.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Beijing Funakang Biotechnology Co., Ltd., established on 2015-02-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Metal Material Sales;Metal Products Sales;Retailing of computer software, hardware and auxiliary equipment;internet sales(Except for products that require a license for sale);Daily necessities sales;Machinery sales;Sales of building materials;Hardware retail;Food Additive Sales;Cosmetics Retail;Cosmetics Wholesale;food sales(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China.

Founded in 2002, Hefei Lifang Pharmaceutical Co., Ltd. is an innovative pharmaceutical enterprise integrating the research and development, production and sales of pharmaceutical preparations and raw materials, and the wholesale and retail of pharmaceuticals and medical devices. It has formed a whole industry for the pharmaceutical industry and pharmaceutical business. Chain coverage, the main industrial products involve cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs, and other fields. Lifang Pharmaceutical owns 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 pharmaceutical retail chain enterprise, and has been successfully listed on the SME board of the Shenzhen Stock Exchange on December 15, 2020.

Wuhan Kexinda Commitment Technology Co., Ltd., established on 2013-02-07, Business scope includes biomedical technology development;computer software,Communication engineering technology development and wholesale and retail;advertising production,Publishing and Proxy;Information system integration;Home appliance repair and wholesale and retail;House to rent(lease)information service;telecommunications,Installation of precision electronic instruments,maintenance and cleaning;network communication equipment(Does not include satellite TV broadcast ground receiving facilities),automation equipment(No special equipment)installation,debugging,maintain;electronic product(Does not include electronic publications),Equipment,Electrical Equipment,Wujinjiaodian,Computer software and hardware,Development of communication equipment,maintain,Wholesale and retail;Anti-corrosion and thermal insulation engineering design,construction;office equipment,Wire and Cable,building materials,Wholesale and retail of decoration materials;marketing planning;property management,Parking lot management;Construction and operation management of new energy vehicle charging and swapping facilities;Business Management Consulting,Educational Consulting(Excluding primary and secondary school culture education and training);Wholesale and retail of prepackaged food.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)